FDA warns Mother Earth Minerals that its Calcium, Magnesium and Silver are unapproved drugs with disease claims and lack quality controls.
What happened
FDA inspected the company's Ogden, Utah facility between August 7 and 15, 2024 and reviewed the product labels collected there, then reviewed the website meminerals.com in September 2024 and January 2025. The website and labels recommend Calcium, Magnesium and Silver for cancer, multiple sclerosis, diabetes and other diseases, which makes them unapproved new drugs. The inspection also found the firm had no ingredient or finished-product specifications, no master manufacturing records, no written quality control procedures and no reserve samples.
What FDA found
The company set no specifications for its ingredients or finished products — not for identity, purity, strength, contamination limits, or labels and packaging.
21 CFR 111.70The company had no written master manufacturing record for any product or batch size.
21 CFR 111.205(a)Batch production records were missing required details such as lot numbers, component weights, yields, the initials of people who weighed or added ingredients, labels, and quality control release.
21 CFR 111.255(b); 21 CFR 111.260The company had no written quality control procedures and could not show that any quality control work was done.
21 CFR 111.103The company did not keep reserve samples of any finished lot it distributed.
21 CFR 111.83The products were promoted on the website and labels to treat or prevent cancer, multiple sclerosis, diabetes, AIDS and other diseases, so they are unapproved new drugs and carry no adequate directions for use.
21 U.S.C. 321(p), 355(a), 352(f)(1)
What FDA wants
FDA asks the company to reply in writing within 15 working days with the specific steps taken to fix each violation, copies of supporting records, and how it will prevent recurrence. If the fixes are not complete by then, the company must explain the delay and give a date for finishing.
Who should pay attention
- retailers and online marketplaces that sell liquid mineral supplements
- contract manufacturers and packagers asked to run products with no specifications or batch records
- consumers and buyers of mineral supplements marketed for serious diseases
This is a summary. Read the original letter on fda.gov.